Libertyville, IL, United States of America

Chunqiu Lai

This inventor holds 14 USPTO granted patents and 12 published patent applications and 3 EPO patents, primarily in Kinase Inhibitors. Top assignees: Abbvie Inc., Karo Bio Ab, Abbott Laboratories Corporation. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunqiu Lai. Retrieved from https://idiyas.com/inventor/chunqiu-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 12)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

Abbott Laboratories Corporation

patents

Years Active: 2006-2020

Loading Chart...

Areas of Expertise:

MCL-1 Inhibitors

CDK9 Kinase Inhibitors

Pyrrolo Compounds

Pyridopyrimidinone

Pyridine Compounds

Tetracyclic Inhibitors

Pyrrolopyridine

Glucocorticoid Receptor Ligands

Metabolic Disorders

Pyridazino Compounds

Pyrrolopyrazine

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

2. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors (2017-10-24),

3. 9718821 - Pyridopyrimidinone inhibitors of kinases (2017-08-01),

4. 9650358 - Pyridine CDK9 kinase inhibitors (2017-05-16),

5. 9328112 - Tetracyclic CDK9 kinase inhibitors (2016-05-03),

6. 9181246 - Pyrrolopyridine inhibitors of kinases (2015-11-10),

7. 9181239 - Pyridopyrimidinone inhibitors of kinases (2015-11-10),

8. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases (2015-06-09),

9. 8969375 - CDK9 kinase inhibitors (2015-03-03),

10. 8822446 - Pyrrolopyridine inhibitors of kinases (2014-09-02),

11. 8435980 - Pyrrolopyridine inhibitors of kinases (2013-05-07),

12. 8383624 - Pyrrolopyrazine inhibitors of kinases (2013-02-26),

13. 7521439 - Glucocorticoid receptor ligands for the treatment of metabolic disorders (2009-04-21),

14. 7141559 - Glucocorticoid receptor ligands for the treatment of metabolic disorders (2006-11-28),

Title: The Innovative Contributions of Chunqiu Lai

Introduction

Chunqiu Lai is a prominent inventor based in Libertyville, IL, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Lai has made remarkable strides in developing compounds that target critical health issues, particularly cancer.

Latest Patents

Among his latest patents are the Macrocyclic MCL-1 inhibitors and methods of use. This patent provides compounds of formula (I) that are useful as agents in the treatment of various diseases and conditions, including cancer. The disclosure also includes pharmaceutical compositions comprising these compounds. Another notable patent is for Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors. This patent outlines compounds of Formula (IIa) that may also be used as agents in the treatment of diseases, including cancer, along with their pharmaceutical compositions.

Career Highlights

Chunqiu Lai has worked with several reputable companies throughout his career, including AbbVie Inc. and Karo Bio AB. His work in these organizations has contributed to the advancement of innovative treatments in the pharmaceutical industry.

Collaborations

Lai has collaborated with notable professionals in his field, including Thomas Dale Penning and Keith W. Woods. These collaborations have further enhanced his research and development efforts.

Conclusion

Chunqiu Lai's innovative work and numerous patents reflect his dedication to improving healthcare through pharmaceutical advancements. His contributions are vital in the ongoing fight against cancer and other diseases.

Profile summary based on public USPTO records.